Table 6.
Clinical characteristics of participants.
| Group | Hepatocellular carcinoma (HCC) (n = 20) | Healthy individuals |
|---|---|---|
| Gender | ||
| Male | 13 | 12 |
| Female | 7 | 8 |
| Age | 55 (42–76) | 43 (20–65) |
| Alpha-fetoprotein (AFP) | ||
| >20 ng/ml | 20 | 0 |
| <20 ng/ml | 0 | 20 |
| Tumor size | 5.57 (2.7–8.6) | — |
| ≤3 cm | 2 | — |
| 3–5 cm | 9 | — |
| >5 cm | 7 | — |
| Not available | 2 | — |
| Barcelona Clinic Liver Cancer (BCLC) stage | ||
| Stage 0 | 0 | — |
| Stage A | 9 | — |
| Stage B | 7 | — |
| Stage C | 0 | — |
| Stage D | 0 | — |
| Not available | 4 | — |
| Viral infection | ||
| HBV | 20 | 0 |
| HCV | 0 | 0 |
| Alcohol | 0 | 0 |
| None | 0 | 20 |
| TNM stage | ||
| T1 | 18 | — |
| T2 | 2 | — |
| T3 | 0 | — |
| T4 | 0 | — |
| Not available | 0 | — |